Correlation Between Pfizer and 090572AQ1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and 090572AQ1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and 090572AQ1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and BIO 37 15 MAR 32, you can compare the effects of market volatilities on Pfizer and 090572AQ1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 090572AQ1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 090572AQ1.

Diversification Opportunities for Pfizer and 090572AQ1

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and 090572AQ1 is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BIO 37 15 MAR 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BIO 37 15 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 090572AQ1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BIO 37 15 has no effect on the direction of Pfizer i.e., Pfizer and 090572AQ1 go up and down completely randomly.

Pair Corralation between Pfizer and 090572AQ1

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 090572AQ1. In addition to that, Pfizer is 1.95 times more volatile than BIO 37 15 MAR 32. It trades about -0.22 of its total potential returns per unit of risk. BIO 37 15 MAR 32 is currently generating about -0.15 per unit of volatility. If you would invest  8,998  in BIO 37 15 MAR 32 on August 30, 2024 and sell it today you would lose (225.00) from holding BIO 37 15 MAR 32 or give up 2.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.91%
ValuesDaily Returns

Pfizer Inc  vs.  BIO 37 15 MAR 32

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
BIO 37 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BIO 37 15 MAR 32 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 090572AQ1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and 090572AQ1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and 090572AQ1

The main advantage of trading using opposite Pfizer and 090572AQ1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 090572AQ1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 090572AQ1 will offset losses from the drop in 090572AQ1's long position.
The idea behind Pfizer Inc and BIO 37 15 MAR 32 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk